Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.

We found that SchB treatment significantly reduced hepatic palmitic acid levels by 12.26% in the HFD-fed mice; while the reductions in fasting mice (6.87%) and in non-fasting mice (2.61%) did not reach statistical significance ( Table 3 ).

also in 111,027 other papers